CtDNA Based MRD Testing for NAC Monitoring in TNBC

Clinical trial NCT06230185 · RECRUITING

Trial details

NCT number: NCT06230185
Sponsor: Personalis Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

TNBC - Triple-Negative Breast Cancer Minimal Residual Disease

Start date: 2023-11-09
Primary completion: 2025-08-30
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.